Global Custom Market Research Reports Provider Company


Immune Design Corp (IMDZ) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America

Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company develops its product candidates through its ZVex and GLAAS discovery platforms. Its product candidates used for the treatment of NY-ESO-1 tumor antigen, merkel cell carcinoma, non-hodgkin lymphoma, and others. It has collaboration with various pharmaceutical companies, to develop its product candidates through its GLAAS platform for the treatment of infectious disease, allergy and autoimmune diseases. The company also operates in San Francisco, California. Immune Design is headquartered in Seattle, Washington, the US.

Immune Design Corp Key Recent Developments

Nov 07,2017: Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates
Nov 01,2017: Immune Design Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Sep 25,2017: Immune Design Announces Upcoming Presentation at the SITC 32nd Annual Meeting
Aug 02,2017: Immune Design Reports Second Quarter 2017 Financial Results and Provides Corporate Update
May 17,2017: Immune Design Reports First Quarter 2017 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of Immune Design Corp provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immune Design Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

Immune Design Corp - Key Information
Immune Design Corp - Overview
Immune Design Corp - Key Employees
Immune Design Corp - Key Employee Biographies
Immune Design Corp - Key Operational Heads
Immune Design Corp - Major Products and Services
Immune Design Corp - History
Immune Design Corp - Company Statement
Immune Design Corp - Locations And Subsidiaries
Immune Design Corp - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Immune Design Corp - Business Description
Immune Design Corp - Corporate Strategy
Immune Design Corp - SWOT Analysis
SWOT Analysis - Overview
Immune Design Corp - Strengths
Immune Design Corp - Weaknesses
Immune Design Corp - Opportunities
Immune Design Corp - Threats
Immune Design Corp - Key Competitors

Section 3 - Company Financial Performance Charts

Immune Design Corp - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Immune Design Corp, Key Information
Immune Design Corp, Key Ratios
Immune Design Corp, Share Data
Immune Design Corp, Major Products and Services
Immune Design Corp, History
Immune Design Corp, Key Employees
Immune Design Corp, Key Employee Biographies
Immune Design Corp, Key Operational Heads
Immune Design Corp, Other Locations
Immune Design Corp, Subsidiaries
Immune Design Corp, Key Manufacturing facilities
Immune Design Corp, Key Competitors
Immune Design Corp, SWOT Analysis
Immune Design Corp, Ratios based on current share price
Immune Design Corp, Annual Ratios
Immune Design Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Immune Design Corp, Performance Chart
Immune Design Corp, Ratio Charts

Primary Immune Deficiency (PID) - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H2 2018, provides an overview

View Report

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2018, provides an

View Report

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Cancer immunotherapy, which can predominantly be classed as a form

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports